ReShape Lifesciences Inc

General ticker "RSLS" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $2.6M

ReShape Lifesciences Inc does not follow the US Stock Market performance with the rate: -35.5%.

Estimated limits based on current volatility of 4.2%: low 4.29$, high 4.67$

Factors to consider:

  • US accounted for 82.1% of revenue in the fiscal year ended 2022-12-31
  • Current price 16.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.08$, 23.71$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.43$, 10.57$]

Similar symbols

Short-term RSLS quotes

Long-term RSLS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $13.60MM $10.71MM $8.68MM
Operating Expenses $71.48MM $57.06MM $23.32MM
Operating Income $-57.88MM $-46.35MM $-14.64MM
Non-Operating Income $-5.54MM $-0.24MM $3.30MM
Interest Expense $0.83MM $0.11MM $0.00MM
R&D Expense $2.52MM $2.54MM $2.31MM
Income(Loss) $-63.42MM $-46.59MM $-11.34MM
Taxes $-0.27MM $-0.38MM $0.05MM
Profit(Loss) $-63.15MM $-46.21MM $-11.39MM
Stockholders Equity $44.33MM $3.66MM $6.66MM
Inventory $3.00MM $3.61MM $3.74MM
Assets $52.53MM $11.14MM $10.66MM
Operating Cash Flow $-15.38MM $-21.90MM $-16.96MM
Capital expenditure $0.35MM $0.13MM $0.04MM
Investing Cash Flow $1.85MM $-0.09MM $-0.01MM
Financing Cash Flow $33.30MM $3.13MM $17.57MM
Earnings Per Share* $-16,438.36 $-6,316.20 $-110.88

* EPS are Split Adjusted, recent splits may be reflected with a delay.